376 related articles for article (PubMed ID: 15644047)
1. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
[TBL] [Abstract][Full Text] [Related]
2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
6. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.
Vu C; Ng YY
Singapore Med J; 2000 Oct; 41(10):478-81. PubMed ID: 11281437
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
9. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
10. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
Howden CW; Leontiadis GI
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
[TBL] [Abstract][Full Text] [Related]
11. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
Manuel D; Cutler A; Goldstein J; Fennerty MB; Brown K
Aliment Pharmacol Ther; 2007 Jun; 25(12):1423-7. PubMed ID: 17539981
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of peptic ulcer in 4943 inpatients.
Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
Graham DY
Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
16. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
17. Does Helicobacter pylori infection explain all socio-economic differences in peptic ulcer incidence? Genetic and psychosocial markers for incident peptic ulcer disease in a large cohort of Danish adults.
Rosenstock SJ; Jørgensen T; Bonnevie O; Andersen LP
Scand J Gastroenterol; 2004 Sep; 39(9):823-9. PubMed ID: 15513379
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and non-malignant diseases.
Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
[TBL] [Abstract][Full Text] [Related]
19. Aging and upper gastrointestinal disorders.
Pilotto A
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():73-81. PubMed ID: 15588798
[TBL] [Abstract][Full Text] [Related]
20. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]